ArticleScientific reports2026
Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Homeostasis of the skin relies on meticulous regulation of integrated pathways. Within this network, ERBB receptors are of great importance in controlling the proliferation, differentiation, and survival of epidermal and hair follicle (HF) keratinocytes as well as sebaceous glands (SGs) in the skin. Consequently, leucine-rich repeats and immunoglobulin-like domains (LRIG) protein family comprising LRIG1, LRIG2, and LRIG3 as one of the fundamental regulators of ERBB receptors plays a pivotal role in tissue development and homeostasis. The function of LRIGs in maintaining skin homeostasis is primarily understood due to the most extensively studied member, LRIG1. However, the role of LRIG3, the last member of this protein family in the skin, is unknown. While its function has been demonstrated in development and maintenance of the homeostasis of various tissues such as inner ear and neural crest morphogenesis via modulating NOTCH and fibroblast growth factor signaling pathways, respectively. Here, we provided the first insights into how Lrig3 overexpression in mouse skin, using the Tet-Off-System, influences cutaneous homeostasis. After overcoming the prenatal lethality of Lrig3 overexpression and obtaining an adequate number of skin-specific Lrig3 transgenic (Lrig3-TG) mice, the first clinical feature was hair loss in these mice. Subsequent investigations revealed extensive changes in the skin protein profile, particularly in keratinocyte differentiation as well as HF and SG markers, along with altered signaling pathways governing HF development. Our study implies up-regulation of the components of ERBB, NOTCH, PI3K/AKT pathways in the skin of Lrig3-TG mice, suggesting a potential role of the Lrig3 in maintaining skin balance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.